Neutrophil dysfunction induced by hyperglycemia: modulation of myeloperoxidase activity

Cláudia de Souza Ferreira1, Tomaz Henrique Araújo, Marilene Lopes Ângelo

  • 1Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, UNIFAL-MG, Alfenas, Minas Gerais, Brazil.

Insights

Hyperglycemia impairs neutrophil function in rats by decreasing myeloperoxidase (MPO) activity, which is crucial for killing Candida albicans. This leads to reduced phagocytic and microbicidal capabilities in diabetic neutrophils.

Area of Science:

  • Immunology
  • Biochemistry
  • Microbiology

Background:

  • Neutrophils are critical for host defense, employing enzymes like NADPH oxidase and myeloperoxidase (MPO) for microbial killing.
  • Hyperglycemia, a hallmark of diabetes, is known to affect immune cell function, potentially compromising innate immunity.

Purpose of the Study:

  • To investigate the impact of hyperglycemia on neutrophil enzyme activity, specifically NADPH oxidase and MPO.
  • To evaluate the consequences of altered enzyme function on the phagocytosis and microbicidal activity against Candida albicans in a rat model.

Main Methods:

  • Assessed NADPH oxidase activity using chemiluminescence and cytochrome C reduction.
  • Measured MPO activity via HOCl production and analyzed MPO expression using Western blot and immunofluorescence.
  • Evaluated Candida albicans phagocytosis and killing using microscopy and May-Grunwald-Giemsa staining.

Main Results:

  • Neutrophils from hyperglycemic rats showed slightly delayed ROS generation kinetics.
  • MPO expression was elevated, but MPO activity was significantly decreased in diabetic neutrophils.
  • Phagocytosis and killing of Candida albicans were impaired in neutrophils from hyperglycemic rats.

Conclusions:

  • Decreased MPO activity and subsequent reduced HOCl production contribute to impaired neutrophil phagocytic and microbicidal functions in hyperglycemic rats.
  • Myeloperoxidase plays a vital role in the microbicidal capacity of neutrophils, and its dysfunction under hyperglycemia has significant implications for host defense.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.